TFF PHARMACEUTICALS, INC. Capital Expenditures
TFF PHARMACEUTICALS, INC. reported Capital Expenditures of $94.75 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2024-11-20
- TFF PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2023-12-31 was $46.39K, a 67.14% decline year-over-year.
- TFF PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2023-09-30 was $12.65K, a 98.37% decline year-over-year.
- TFF PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2022-12-31 was $141.17K, a 11.46% increase year-over-year.
- TFF PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2022-09-30 was $777.48K, a 448.90% increase year-over-year.
- TFF PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $94.75K, a 93.89% decline from fiscal 2022.
- TFF PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $1.55M, a 78.62% increase from fiscal 2021.
- TFF PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for fiscal 2021 was $868.50K, a 21.25% decline from fiscal 2020.
- TFF PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for fiscal 2020 was $1.10M.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2023-12-31 | $46.39K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $59.04K derived: sum of 2 quarters · filed 2024-11-20 | $94.75K 10-K · filed 2024-03-28 | |
| 2023-09-30 | $12.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-20 | $48.36K 10-Q · filed 2024-11-20 | ||
| 2023-06-30 | $35.71K 10-Q · filed 2024-08-14 | |||
| 2022-12-31 | $141.17K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $918.64K derived: sum of 2 quarters · filed 2024-03-28 | $1.41M derived: sum of 3 quarters · filed 2024-03-28 | $1.55M 10-K · filed 2024-03-28 |
| 2022-09-30 | $777.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $1.27M derived: sum of 2 quarters · filed 2023-11-14 | $1.41M 10-Q · filed 2023-11-14 | $1.54M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $495.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $632.68K 10-Q · filed 2023-08-14 | $759.34K derived: sum of 3 quarters · filed 2023-08-14 | $900.98K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $137.23K 10-Q · filed 2023-05-11 | $263.88K derived: sum of 2 quarters · filed 2023-05-11 | $405.53K derived: sum of 3 quarters · filed 2023-05-11 | $529.61K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $126.65K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $268.30K derived: sum of 2 quarters · filed 2023-03-31 | $392.38K derived: sum of 3 quarters · filed 2023-03-31 | $868.50K 10-K · filed 2023-03-31 |
| 2021-09-30 | $141.64K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $265.73K derived: sum of 2 quarters · filed 2021-11-15 | $741.85K 10-Q · filed 2021-11-15 | $1.55M derived: sum of 4 quarters · filed 2022-05-11 |
| 2021-06-30 | $124.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $600.21K 10-Q · filed 2021-08-12 | $1.41M derived: sum of 3 quarters · filed 2022-05-11 | |
| 2021-03-31 | $476.13K 10-Q · filed 2022-05-11 | $1.29M derived: sum of 2 quarters · filed 2022-05-11 | ||
| 2020-12-31 | $809.57K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $1.10M 10-K · filed 2022-03-24 | ||
| 2020-09-30 | $293.24K 10-Q · filed 2021-11-15 |